T. Rowe Price Associates’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-60,900
Closed -$485K 2606
2015
Q1
$485K Hold
60,900
﹤0.01% 1990
2014
Q4
$345K Hold
60,900
﹤0.01% 2120
2014
Q3
$301K Buy
60,900
+9,000
+17% +$48.7K ﹤0.01% 2150
2014
Q2
$296K Hold
51,900
﹤0.01% 2183
2014
Q1
$384K Sell
51,900
-15,000
-22% -$110K ﹤0.01% 2028
2013
Q4
$479K Hold
66,900
﹤0.01% 1923
2013
Q3
$519K Buy
66,900
+22,800
+52% +$177K ﹤0.01% 1881
2013
Q2
$288K Buy
+44,100
New +$277K ﹤0.01% 2079

T. Rowe Price Associates's ELX Position: Q2 2015 in Review

T. Rowe Price Associates sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 60,900 shares — an estimated $485K sold.

T. Rowe Price Associates first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $519K in Q3 2013. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • T. Rowe Price Associates reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 60,900 EMULEX CORP shares in Q2 2015, an estimated $485K.
  • T. Rowe Price Associates first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • T. Rowe Price Associates's EMULEX CORP position peaked at $519K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.